WhizAI, a Somerset, NJ-based first and only purpose-built, augmented consumer platform for the life sciences industry, raised $8 million in series A financing to bring the future of analytics to the life sciences industry.
The round was led by Vertical Venture Partners, existing investors also participated. This latest investment brings the total amount raised by the company to over $15 million.
The company will use the capital to grow its industry footprint by expanding its team across the globe and investing in sales and marketing so that more companies can get the fast, easy, and contextual insights necessary to compete.
Company: Whizdotai, Inc.
Round: Series A
Funding Month: December 2021
Lead Investors: Vertical Venture Partners
Company Website: https://www.whiz.ai/
Software Category: Augmented consumer platform
About the Company: WhizAI is the first and only augmented consumer platform purpose-built for the life sciences industry. It puts insights directly into the hands of business users empowering decision-makers to drive more informed and faster business decisions at a lower cost. With its deep understanding of the life sciences domain and user intent, the platform delivers insights without the delays of traditional BI dashboards. Fast, easy, and scalable, WhizAI is transforming analytics with artificial intelligence optimized for life sciences making WhizAI the trusted partner of choice at top global life sciences companies.